DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Hotta N, Akanuma Y, Kawamori R , et al.
Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.
Diabetes Care 2006;
29 (7) 1538-1544
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.